INDmoney
Divis Laboratories Share Price
₹6364.50
+48.50
(+0.77%)
as on
Divis Laboratories Stock Performance
as on March 5, 2026 at 9:31 pm IST
Day's Low
Day's High
₹6,300.00₹6,395.00
1.01%
Downside
0.48%
Upside
52 Week's Low
52 Week's High
₹4,955.00₹7,071.5022.15%
Downside
11.11%
Upside
Divis Laboratories share price movements today
- Previous Close
- ₹6,316.00
- Open
- ₹6,316.50
- Volume
- 2.91L
- Upper Circuit
- ₹6,947.50
- Lower Circuit
- ₹5,684.50
- Day's Low - High
- ₹6,300.00 - ₹6,395.00
- 52 Week Low - High
- ₹4,955.00 - ₹7,071.50
Divis Laboratories Historical Returns
- 1 Month Return
- + 2.84 %
- 3 Month Return
- -2.43 %
- 1 Year Return
- + 14.49 %
- 3 Year Return
- + 121.86 %
- 5 Year Return
- + 80.62 %
Divis Laboratories Fundamentals
as on March 5, 2026 at 4:01 pm IST
Market Cap
₹1,67,669.96 Cr
Return on Equity (ROE)
15.57
PE Ratio (TTM)
67.64
Return on capital employed (ROCE)
20.63
Industry PE ratio
42.01
Beta (LTM)
0.75
P/B Ratio
10.27
Dividend Yield
0.52
PEG Ratio
4.36
Quarterly Earnings Growth YOY
-1.02
EPS (TTM)
82.68
Sector
Pharmaceuticals
Book Value
564.87
Technical Analysis
Bullish
View Technical Analysis
Divis Laboratories Stock Valuation
as on March 5, 2026 at 4:01 pm IST
Divis Laboratories in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (42.01x)
March 4, 2026
Today (67.64x)
March 4, 2026
Highest (90.48x)
December 4, 2024
Today’s Price to Earnings Ratio: 67.64x
Divis Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Divis Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,67,669.96 | 16.12% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,46,919.17 | 49.97% | 0.66 | 1,911 | 11,516 | |
| BUY | 61,327.05 | -0.82% | 0.78 | 1,429 | 15,261 | |
| BUY | 28,146.99 | -6.6% | 0.53 | 698 | 5,616 | |
| BUY | 1,06,077.76 | 12.62% | 0.51 | 5,291 | 27,547 |
Market expectation of Divis Laboratories Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
50.00%
Buy
17.86%
Hold
32.14%
Sell
Divis Laboratories Stock’s Investor Sentiment and Interest
Investment in Divis Laboratories Ltd Shares on INDmoney has dropped by -11.37% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Divis Laboratories Ltd Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:5% versus previous 30 day period
Divis Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Divis Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Divis Laboratories Ltd Cash Flow
Figures in Rupees Crores
Divis Laboratories Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Divis Laboratories Stock
Check out the Mutual Funds with significant holdings in Divis Laboratories.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 SBI Equity Hybrid Fund Direct Growth | 2.46% | 3300000 | |
SBI Large Cap Fund Direct Growth | 3.02% | 2731710 | |
SBI Focused Fund Direct Plan Growth | 2.49% | 1770000 | |
 Axis ELSS Tax Saver Fund Direct Plan Growth Option | 2.11% | 1145984 | |
SBI Multicap Fund Direct Growth | 2.42% | 920000 |
Divis Laboratories Corporate Actions
View detailed summary of the earnings and dividend history of Divis Laboratories.
Divis Laboratories Ltd Earnings Results
Divis Laboratories Ltd’s net profit fell -1.02% since last year same period to ₹583.00Cr in the Q3 2025-2026. On a quarterly growth basis, Divis Laboratories Ltd has generated -15.38% fall in its net profits since last 3-months.
Read More about Earnings ResultsDivis Laboratories Ltd Dividends May,2025
In the quarter ending March 2025, Divis Laboratories Ltd has declared dividend of ₹30.00 per share on 17 May 2025 - translating a dividend yield of 0.95%.
Read More about Dividends
Indices Featuring Divis Laboratories Stock
Check stock indices that include Divis Laboratories.
Insights on Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, DIVISLAB stock has moved up by 2.8%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 19.39% to 20.08% in Dec 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 45.7% return, outperforming this stock by 31.2%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 188.9% return, outperforming this stock by 67.1%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 2.86K Cr → 2.69K Cr (in ₹), with an average decrease of 5.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 8.96% to 8.76% in Dec 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 13.99% to 13.73% in Dec 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 689.0 Cr → 583.0 Cr (in ₹), with an average decrease of 15.4% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 51.89% to 51.88% in Dec 2025 quarter
Divis Laboratories Stock Futures & Options Contracts
View the latest movement in Divis Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.
Divis Laboratories Options
Divis Laboratories Futures
About Divis Laboratories Ltd
Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.
Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.
Revenue: ₹2,604.00Cr as on December 2025 (Q3 FY26)
Net Profit: ₹583.00Cr as on December 2025 (Q3 FY26)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
| Organisation | Divis Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | Ramesh B V Nimmagadda |
| E-voting on shares | Click here to vote |
FAQs
What is Divis Laboratories share price today?
Divis Laboratories share price today stands at ₹6364.5 as on at the close of the market. Divis Laboratories share today touched a day high of ₹6395 and a low of ₹6300.
What is the 52 week high and 52 week low range for Divis Laboratories share?
Divis Laboratories touched a 52 week high of ₹7071.5 and a 52 week low of ₹4955. Divis Laboratories share price today i.e. is closed at ₹6364.5, which is -10.00% down from its 52 week high and 28.45% up from its 52 week low.
What is Divis Laboratories's market capitalisation today?
Divis Laboratories market capitalisation is ₹1,67,669.96 Cr as on .
How to buy Divis Laboratories shares?
To buy Divis Laboratories shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for DIVISLAB or Divis Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Divis Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Divis Laboratories trading volume today?
Divis Laboratories trading volume is 2.91L as on . This means that 2.91L shares of Divis Laboratories were bought and sold on the stock market during today's trading session.